Loading

Panel: Accelerated approval in 2026: A necessary tool or a commercial liability?

21 Jan 2027
Theatre 4
Commercializing Advanced Therapies
Speakers
Chris Juenger, Director, Lead, North America Regulatory Science, Policy and Intelligence - CSL
Snehal Naik, Vice President, Science and Regulatory - BIO

Topic

Clinical Development & Regulatory Strategy

Persona

Biotech,Pharma,Regulators & Policy Makers